SUSQUEHANNA INTERNATIONAL GROUP, LLP historic quarter change: Foreign Options, Sold out
In put and call options, at their filed underlying value (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, SUSQUEHANNA INTERNATIONAL GROUP, LLP opened 888 positions, added to 3,640, reduced 3,730 and sold out of 924.
- Q2 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR · Call; Shares before 305,500.
- Q2 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR · Put; Shares before 38,800.
- Q2 2026: Stock CNTA; Country of operation —; Class SPONSORED ADS · Put; Shares before 173,400.
- Q2 2026: Stock CNTA; Country of operation —; Class SPONSORED ADS · Call; Shares before 118,800.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1446194), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-14); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-15); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-26); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-17); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-09-30. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | United States | $870.940B | 13,579 |
| NORGES BANK | Norway | $864.691B | 1,507 |
| JANE STREET GROUP, LLC | United States | $777.217B | 19,058 |
| NORTHERN TRUST CORP | United States | $756.585B | 19,864 |
| Capital World Investors | United States | $732.940B | 620 |
| UBS Group AG | Switzerland | $666.317B | 22,771 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | United States | $654.473B | 3,645 |
| Invesco Ltd. | United States | $653.294B | 23,552 |
| Capital Research Global Investors | United States | $644.560B | 459 |
| CITADEL ADVISORS LLC | United States | $618.473B | 15,589 |